Capital A Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Capital A Wealth Management's BMY Position: Q2 2025 in Review
Capital A Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 28 shares — an estimated $1.71K sold.
Capital A Wealth Management first reported a position in BMY in Q4 2024 and held it in 2 quarters. The position peaked at $1.71K in Q1 2025. 2,293 funds tracked by Wall St. Rank hold BMY as of Q2 2025.
- Capital A Wealth Management reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
- Capital A Wealth Management sold 28 Bristol-Myers Squibb shares in Q2 2025, an estimated $1.71K.
- Capital A Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2024 and held it in 2 quarters.
- Capital A Wealth Management's Bristol-Myers Squibb position peaked at $1.71K in Q1 2025.
- 2,293 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.
Based on Capital A Wealth Management's 13F filing for Q2 2025, filed 26 Sep 2025.